Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Excipients
40 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Viscosity Reduction
Viscosity Reduction with An Excipient Platform and Feasibility Testing Service
PAO-08-23-CL-03
Alternative Excipient
Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products
PAO-08-23-CL-01
Modified-Release Drug Formulations
Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores
PAO-05-23-CL-06
Distribution
Redefining Innovation and Growth in Pharmaceutical Distribution
PAO-06-23-CL-03
3D Printing
Advancing Extrusion-Based 3D Printing for Drug Production
PAO-11-022-CL-14
Sweeteners
High-Intensity Sweeteners for Taste Optimization
PAO-11-022-CL-12
Taste Masking Formulations
Formulating Flexibility with ActiMask® Taste Masking
PAO-10-022-CL-05
Lipid Excipients
Regulatory Considerations for Lipid Excipients
PAO-07-022-CL-04
Excipient Quality Assurance
Assuring Excipient Quality for Parenteral Products
Advanced Excipients
How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs
PAO-04-022-CL-07
Excipients
Enabling Stable, High-Viscosity Injectable Drug Products with New Excipient Combinations
PAO-01-22-CL-02
Formulation
Incorporating Patient Voices from the Start of Drug Development
PAO-01-22-R250-10
Formulation
Accelerating Biologics Development with High-Quality Protein Stabilization Excipients
PAO-11-21-CL-12
Tablet Coating
An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility
PAO-09-21-CL-06
Orally Disintegrating Tablets
A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs
PAO-07-21-CL-03
Hot Melt Extrusion
Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion
PAP-Q4-20-CL-016
The Future of Healthcare
How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-009
Orally Disintegrating Tablets
Qualifying ODT Excipient Systems Beyond Disintegration Performance
PAO-10-20-CL-03
Wet Granulation
The Application of Mannitol In Wet Granulation
PAO-10-20-CL-01
The Future of Healthcare
How Is SPI Pharma Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-004
Excipients
New Mannitol Formulations Are a Gem of a Collection
PAP-Q1-20-CL-004
Collaboration
Context Therapeutics Signs Strategic Research Collaborations for Apristor® (onapristone extended release) With Key Academic Leaders in the Progesterone Receptor (PR) and Breast Cancer Fields
PR-M08-18-NI-086
Manufacturing
Colorcon Up and Running in Puerto Rico
PAO-M03-18-NI-011
Excipients
Celanese on the Road to BIO: Excipients In Biologics
PTV-M06-17-CL-010
1
2
»